Takeda Pharmaceutical Co - ADR Live Stock Price Today, Share Analysis and Chart

Name: Takeda Pharmaceutical Co - ADR: Is Infosys Ltd. worth buying?
Item: Takeda Pharmaceutical Co - ADR
Rating: 1.992694375
Author: Trendlyne DVM scores

Expensive Performer

about

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, whi...

14.29 0.05 (0.35%)

2.7M

XNYS Volume

XNYS 14 Nov, 2025 4:30 PM (EST)

Medium Financial Strength

44.4 / 100

Expensive Valuation

29.7 / 100

Technically Neutral

40.9 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 24%

3 analysts

Takeda Pharmaceutical Co ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..